
Mint Med Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.8/10
Best for: flat-price compounded GLP-1 with no membership; the lowest rates need a longer plan
Price is where Mint Med scores best in our breakdown.
Semaglutide
Tirzepatide
Price checked on Mint Med’s site,
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not stated
Coaching
Not stated
No insurance needed · Vetted by our editors
Mint Med is a national, no-membership telehealth platform (distinct from Utah's Mint Medical Clinic) offering compounded semaglutide and tirzepatide at one locked price for every dose. Month-to-month plans are $89/mo for semaglutide and $119/mo for tirzepatide, with lower rates on 3- and 6-month prepaid plans. It is HSA/FSA eligible and serves 36 listed states.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money
Vetted alternatives to Mint Med
Ro
Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help
Editorial score · methodology
Collective
Best for: the lowest flat medication price if you can absorb an annual membership fee
Editorial score · methodology
CoreAge Rx
Best for: lowest-price compounded semaglutide and tirzepatide with one flat price at every dose
Editorial score · methodology
Mint Med at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $89/mo
- Pricing model
- Flat: dose increases don't raise the monthly price
- What's included
- Medication · Consult · Shipping
- Availability
- 36 states
- FDA status
- 1 FDA warning letter on record; see below
How we scored Mint Med
Each dimension is scored algorithmically from Mint Med’s published pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.
Value25%
9.4/10At $89/mo, Mint Med runs about 50% below the $179 median for GLP-1 providers (each program's lowest listed ongoing monthly price for compounded semaglutide). Pricing is flat across doses, so there is no escalation markup as you titrate up.
Effectiveness25%
8.2/10Mint Med offers both semaglutide and tirzepatide, the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
7.5/10Online intake and platform experience (consult included in the price); 8 platform features disclosed.
Trust & Safety15%
6.2/10Key details fully confirmed by our editors; an FDA warning letter is on file (see flag above).
Accessibility10%
7.8/10Mint Med is available in 36 states. FSA/HSA cards are accepted.
Support10%
6.0/10Mint Med provides standard clinician follow-up; no extended coaching or community program is disclosed.
Each checked against the provider’s own site.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this Mint Med review
Last checked October 2026- Confirmed current pricing across 2 dose/plan tiers
- Confirmed availability in 36 states
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the provider's public sign-up flow, stopping before payment
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: high.
What we checked
- Provider's own pricing page
- $89–$119/mo across 2 dose/plan tiers (checked October 2026)
- State pharmacy licensing & LegitScript status
- LegitScript Verified
- FDA warning-letter register
- An active letter is on file for this provider; see below
What to expect when you sign up with Mint Med
We walked Mint Med’s public signup flow in October 2026 to document the process (the steps, pricing transparency, and what’s required) before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Choose compounded semaglutide or tirzepatide from the Weight Management collection.
- 2Pick a plan on the product page: month-to-month, 3-month or 6-month prepaid, each with its price shown.
- 3Click Check if You Qualify; the intake flow offers 'Get Pricing Information,' then asks for your name, email and phone before continuing.
- Plan prices are shown on the product page before any intake.
- Payment is collected up front to start clinical review; Mint Med says it refunds you right away if you're not medically eligible.
- States that require it prompt you to schedule a live video or audio visit; other states use asynchronous review.
- Cancellation needs an online form submitted at least 48 business hours before the next order processes.
- Prescriptions are processed within 24-48 business hours after approval; shipping takes 5-7 business days with tracking.
- The homepage banner advertises $106 a month, which doesn't match the $89 plan on the semaglutide product page.
Mint Med customer support
- Phone
- 1-513-826-6142
- help@mintmed.com
- Hours
- Mon-Fri 9AM-5PM EST
GLP-1 medications Mint Med offers
Tap any medication to read our plain-English guide: how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
$89 billed every month; price locked at every dose. Longer plans: 3-mo $85/mo ($255 every 3 months), 6-mo $80/mo ($480 every 6 months).
$119 billed every month; price locked at every dose. Longer plans: 3-mo $110/mo ($330 every 3 months), 6-mo $99/mo ($594 every 6 months).
Ready to get started?
Plans and promotions change often, so check Mint Med's current pricing and active discounts before you decide.
What we like
- Low flat pricing: $89/mo for semaglutide and $119/mo for tirzepatide, month to month
- Your price is locked and doesn't rise as your dose increases
- No membership fee; provider evaluation, medication and cold-packed shipping are included
- Refund if you're found not medically eligible
- LegitScript certification seal displayed
- HSA/FSA eligible
- Lists its 36 states by name and names a supervising physician
- US-based phone support on weekdays
Watch-outs
- The FDA sent the company a warning letter in June 2026 over its compounded GLP-1 marketing
- Payment is collected up front, before the provider review
- Cancel at least 48 business hours before your next order processes, via an online form
- Leaving a 3- or 6-month prepaid plan early means paying the difference up to the full price
- No refunds once an order has been processed
- Prices differ across the site ($89, $106 and $129 a month all appear for semaglutide)
- Compounding pharmacy partners are not named
- Trustpilot rating is 2.6 out of 5 from 15 reviews
Mint Med: one low price for every dose, no membership attached
Mint Med is a national, online-only telehealth platform built around one idea that makes it easy to evaluate. You pay one flat monthly price for compounded semaglutide or tirzepatide, and that price doesn't change as you titrate up. Month to month, semaglutide is $89 and tirzepatide is $119, with no membership fee on top. For anyone burned by a platform that raised the bill with every dose increase, that flat structure is the whole pitch.
One housekeeping note first. Mint Med is not the same company as Mint Medical Clinic, a Utah-only in-person clinic reviewed separately on this site. They share a name and nothing else, so if you were looking for the Utah hybrid clinic, you want a different listing.
How the pricing works
The product pages call it a 'Lifetime Price (All Doses Included),' and the terms say your price is locked. Many competitors apply the headline number only to the lowest dose, then climb past two hundred dollars a month as you move up. Mint Med doesn't. At $89 a month for semaglutide, it sits far below the $179 category median we track. The plan includes the provider evaluation, the medication if approved and free cold-packed shipping.
How we get the market median: $179 is the middle value of each program's lowest listed ongoing monthly price for compounded semaglutide (month to month, not a first-month promo, a prepaid plan or a price with a membership on top), across the 121 programs that publish one.
Three- and six-month prepaid plans lower the monthly rate a little further. Read the fine print before you choose one, though. If you cancel a prepaid plan early, you have to pay the difference between the promotional and full price. Month-to-month has no such clawback. The site also isn't consistent: a homepage banner advertises $106 a month, and an older product page still shows $129. The plan picker on the main product page is the one to trust.
- Semaglutide: $89 a month, month to month, at every dose
- Tirzepatide: $119 a month, month to month, at every dose
- Every plan includes the provider evaluation, medication and free cold-packed shipping, with no membership fee
- Prepaid plans carry lower monthly rates, but canceling early means paying back the discount
- You can pay with HSA/FSA funds
The medications, and how they reach you
Mint Med offers two compounded injectables, semaglutide and tirzepatide, the molecules in Wegovy and Zepbound. It doesn't sell brand-name pens, an oral version or liraglutide. The trust page says the medications come from licensed 503A compounding pharmacies, though it doesn't name them. The site publishes the FDA's standard disclaimer that compounded drugs aren't FDA-reviewed for safety or effectiveness.
You pay up front to start the clinical review, and Mint Med refunds you right away if you aren't medically eligible. Most states use an asynchronous questionnaire reviewed by a licensed clinician. States that require it prompt you to schedule a live video or audio visit. After approval, prescriptions process within one to two business days, and shipping takes five to seven business days with tracking.
Cancellation and refunds
You can cancel a month-to-month plan anytime. The request goes through an online form and has to arrive at least 48 business hours before your next order processes. Once a prescription has been processed, it's final, with no refund. That's stricter than the 'cancel anytime' badge suggests, so set a reminder well before your refill date.
Trust and oversight: solid signals, clear concerns
Mint Med publishes more of the basics than most. It displays a LegitScript seal, lists all 36 states it serves by name and names a supervising physician, Dr. Roderick Huff, MD. It offers US-based phone support on weekdays. The weak spots are just as concrete. The FDA sent the company, Glow Medispa, LLC doing business as Mint Med, a warning letter in June 2026 over its compounded GLP-1 marketing, covered in the regulatory notice below. Its Trustpilot rating is 2.6 out of 5 from 15 reviews. You can see how we weigh these factors in our scoring methodology.
Who should choose Mint Med, and who shouldn't
Choose it if you want one of the lowest flat prices we track, a rate that won't climb with your dose, no membership and HSA/FSA payment. Month-to-month is the cleaner choice unless you're sure you'll stay the full prepaid term.
Skip it if you want brand-name Wegovy or Zepbound, or if you live outside its 36 states. Mondae also holds one price at every dose and says it serves all 50 states. It's also a weaker fit if the FDA letter or the low Trustpilot score gives you pause, or if you want to know which pharmacy compounds your medication.
Bottom line
Mint Med offers flat, membership-free pricing on compounded semaglutide and tirzepatide, now at $89 and $119 a month. That's among the lowest we track, and the price stays put as the dose goes up. The trade-offs are an FDA warning letter on file, a weak Trustpilot record, unnamed pharmacies and a 48-business-hour cancellation window. If price is your main filter and you go month to month, it's a strong value.
The Bottom Line
Price is where Mint Med scores best in our breakdown.
Ready to start with Mint Med?
From $89/mo. See current pricing and start your free consultation.
Mint Med might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
- If you want brand-name Ozempic, Wegovy, Mounjaro or Zepbound, consider altRX.
- If you want built-in coaching and behavior-change support, consider Ro.
- If you live outside its coverage area and need nationwide access, consider CoreAge Rx.
Head-to-head
Compare Mint Med vs…
Mint Med scores7.8/10
Side-by-side pricing, medications and scores. Pick a matchup.
Mint Med vs Amazon One Medical
Amazon One Medical scores 8.5/10

Mint Med vs Vytora Health
Vytora Health scores 8.4/10
Scores are our independent editorial ratings out of 10.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Regulatory notice
Mint Med received an FDA warning letter dated June 8, 2026
The letter concerns false & misleading claims/misbranded (telehealth). FDA warning letters are public regulatory communications and do not, on their own, constitute a finding of illegal activity. Companies often respond with corrective action.
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Mint Med review:
Sources & methodology (as of November 2026)
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See Mint Med's current pricing
Plans from $89/mo. Start your free consultation to check eligibility and today's price.